United Therapeutics
UTHR · NASDAQ
Bulios Fair Price
$500.42
0.7% upside
Trenutna cena
$497.11
Po podatkih Bulios Fair Price se delnica UTHR trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
United Therapeutics Corporation is an American biotechnology company headquartered in Silver Spring, Maryland. The company focuses on the development and manufacturing of drugs for the treatment of pulmonary arterial hypertension and other pulmonary and vascular-related diseases. Their main drugs include therapies for the treatment of pulmonary arterial hypertension and carcinoid syndrome. United Therapeutics is also involved in research and development of new drug formulations in the field of regenerative medicine and organ transplantation. The company is known for its innovative approach to treating pulmonary diseases and comprehensive research in the field of biotechnology. Shares of United Therapeutics Corporation are publicly traded on the NASDAQ stock exchange.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Martine A. Rothblatt
Employees
1,400
Headquarters
Silver Spring
Prihajajoči dogodki
Earnings
Upcoming earnings report